跳至主要内容
临床试验/NCT02194413
NCT02194413已完成不适用

Effects of Healing Touch on Patients Undergoing Hematopoietic Stem Cell Transplant

University of Iowa1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2012年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
1
主要终点
Length of hospital stay, Days to engraftment defined as absolute neutrophil count (ANC: segs + bands) greater

研究概览

简要总结

This randomized pilot clinical trial studies healing touch or usual care in improving quality of life in patients undergoing stem cell transplant. Healing touch may improve the quality of life of patients undergoing stem cell transplant.

详细描述

Primary Objectives:

I. To estimate the effects of healing touch (HT) vs usual care in the following clinical outcomes of stem cell transplant (SCT) patients; length of hospital stay, days to engraftment, and number of hospital readmissions during 100 days post-transplant.

II. To estimate changes in quality of life (QoL) which occur during hospitalization of SCT patients who receive HT vs. usual care.

III. To examine differences in effects of HT vs. usual care (UC) in patients receiving related allogeneic (Allo) transplant compared to those receiving autologous (Auto) transplant.

OUTLINE: Patients are randomized to 1 of 2 arms.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Currently undergoing autologous (auto) or related allogeneic (related allo) stem cell transplantation
  • •Admitted to the University (U) Adult Blood and Bone Marrow Transplant Unit (UIBMTU) of the University of Iowa Hospitals and Clinic
  • •Ability to provide written informed consent obtained prior to participation in the study and able to complete questionnaires
  • •Pregnant woman who are eligible for stem cell transplant are included in this study

排除标准

  • •Patients with any significant history of non-compliance to medical regimens, with inability to grant a reliable informed consent or unable to complete questionnaires
  • •Patients with evidence of a significant psychiatric disorder by history that would prevent completion of the study will not be allowed to participate, i.e., schizophrenia, anxiety disorder, major depressive disorder and bipolar disorder
  • •Diagnosis of dementia or other disease affecting cognitive function
  • •Nursing women are excluded

研究组 & 干预措施

Arm 1 (healing touch)

Experimental

Patients receive daily HT sessions comprising pain drain, chakra connection, magnetic clearing, and mind clearing over 30 minutes from day 1 until 2 days before discharge from the hospital (therapeutic touch).

Interventions: therapeutic touch, quality-of-life assessment, and questionnaire administration

干预措施: therapeutic touch (Procedure)

Arm 1 (healing touch)

Experimental

Patients receive daily HT sessions comprising pain drain, chakra connection, magnetic clearing, and mind clearing over 30 minutes from day 1 until 2 days before discharge from the hospital (therapeutic touch).

Interventions: therapeutic touch, quality-of-life assessment, and questionnaire administration

干预措施: quality-of-life assessment (Other)

Arm 1 (healing touch)

Experimental

Patients receive daily HT sessions comprising pain drain, chakra connection, magnetic clearing, and mind clearing over 30 minutes from day 1 until 2 days before discharge from the hospital (therapeutic touch).

Interventions: therapeutic touch, quality-of-life assessment, and questionnaire administration

干预措施: questionnaire administration (Other)

Arm II (usual care)

Active Comparator

Patients receive routine nursing care from doctors and nurses from day 1 until 2 days before discharge from the hospital.

Interventions: quality-of-life assessment, and questionnaire administration

干预措施: quality-of-life assessment (Other)

Arm II (usual care)

Active Comparator

Patients receive routine nursing care from doctors and nurses from day 1 until 2 days before discharge from the hospital.

Interventions: quality-of-life assessment, and questionnaire administration

干预措施: questionnaire administration (Other)

结局指标

主要结局

Length of hospital stay, Days to engraftment defined as absolute neutrophil count (ANC: segs + bands) greater

时间窗: Up to 100 days

Changes in QoL (POMS-SF, FACT-BMT, CES-D)

时间窗: Baseline up to 100 days

Changes in levels of QoL measures before and after hospitalization will be compared using the paired t-test or the nonparametric paired sign test, if the assumption of normality is substantially violated.

次要结局

  • Number of hospital readmissions(Up to 100 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Susan Lutgendorf

Professor

University of Iowa

研究点 (1)

Loading locations...

相似试验